Skip to main content
. 2022 Jul 4;12:62. doi: 10.1186/s13613-022-01040-6

Table 2.

Baseline characteristics

Characteristic All
(n = 1834)
No MAKE30
(n = 1315)
MAKE30
(n = 519)
p value
Age, years 67 (56–75) 66 (55–74) 70 (60–77)  < 0.001
Male sex 1021 (55.7%) 740 (56.3%) 281 (54.1%) 0.41
Body weight on ICU admission, kga 78 (66–90) 78 (67–91) 75 (64–88) 0.005
Baseline creatinine, µmol/l 123 (81–189) 119 (80–181) 132 (84–214) 0.001
Baseline creatinine approach 0.51
 Obtained from first creatinine level in ICU 1814 (98.9%) 1303 (99.1%) 511 (98.5%)
 Obtained from pre-admission creatinine level 5 (0.3%) 3 (0.2%) 2 (0.4%)
 Obtained from estimated creatinine level 15 (0.8%) 9 (0.7%) 6 (1.2%)
 Chronic liver disease 152 (8.3%) 84 (6.4%) 68 (13.1%)  < 0.001
 Chronic cardiac disease 307 (16.7%) 203 (15.4%) 104 (20.0%) 0.017
 Chronic respiratory disease 205 (11.2%) 138 (10.5%) 67 (12.9%) 0.14
 Immune deficiency 596 (32.5%) 382 (29.0%) 214 (41.2%)  < 0.001
Location before ICU admission  < 0.001
 Other ICU 83 (4.5%) 67 (5.1%) 16 (3.1%)
 Emergency department 511 (27.9%) 370 (28.1%) 141 (27.2%)
 Recovery 85 (4.6%) 77 (5.9%) 8 (1.5%)
 Operating room 202 (11.0%) 151 (11.5%) 51 (9.8%)
 High dependency unit 82 (4.5%) 50 (3.8%) 32 (6.2%)32 (6.2%)
 Ward 871 (47.5%) 600 (45.6%) 271 (52.2%)
Hospital 0.039
 A 552 (30.1%) 409 (31.1%) 143 (27.6%)
 B 511 (27.9%) 345 (26.2%) 166 (32.0%)
 C 770 (42.0%) 561 (42.7%) 209 (40.3%)

Data are n (%) or median (IQR)

MAKE30 major adverse kidney events within 30 days; ICU intensive care unit

aData available for 1289 (98%) patients in the No MAKE30 group and 509 (98%) patients in the MAKE30 group